Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1998-11-09
2000-09-19
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514539, 560 35, 560116, 560117, A61K 31215, C07C22900, C07C 6974
Patent
active
061213179
ABSTRACT:
Compounds of formula (1), (Gibberellins), and their pharmaceutically acceptable derivatives to promote ulcer-healing, healing of surgical wounds or open fractures and treatment of bronchitis or thrombophlebitis in animals including humans or cultivation of skin cell lines in vitro ##STR1## wherein A is COOR, where R is hydrogen, unsubstituted or substituted C.sub.1-20 alkyl, allyl, aryl, arylalkyl, amidine, NR.sup.4 R.sup.5 or an unsaturated or saturated ring containing one or more hetero-atoms selected from the group consisting of nitrogen, oxygen and sulfur; R.sup.4 and R.sup.5 may or may not be the same, are hydrogen, or C.sub.1-20 alkyl, allyl, aryl, arylalkyl or an unsaturated or saturated ring containing one or more hetero-atoms selected from the group consisting of nitrogen and sulfur; B is hydrogen, hydroxyl, mercaptan, or halogen, or A and B together form a --CO--O-- linkage; R.sup.1 is hydrogen, hydroxyl, mercaptan, halogen, amino, azido, NR.sup.4 R.sup.5, unsubstituted or substituted C.sub.1-20 alkyl, allyl, aryl, arylalkyl, and R.sup.2 is methylene, or a divalent hetero-atom.
REFERENCES:
patent: 4424232 (1984-01-01), Parkinson
patent: 5487899 (1996-01-01), Davis
patent: 5580857 (1996-12-01), Oden
Milman, N., et al., "Lysine Prophylaxis in Recurrent Herpes Simplex Labialis: A Double-Blind, Controlled Crossover Study." Acta Derm Venereal (Stockh) (1980) 60 (1) 85-7.
Milman, N., et al. "Lysine Prophylaxis in Recurrent Labial Herpes Simplex." Ugeskr Laeger, May 5, 1980: 142 (19): 1202-3 (Eng. Abstr.).
Milman, N., et al. "Lysine Therapy of Recurrent Herpes Simplex Labialis." Ugeskr Laeger (Oct. 22, 1979) 141 (43): 2960-2 (Eng. Abstr.).
Spadoni, R., et al. "Lysine P-isobutyl-phenylpropinate in Articular and Extra-articular Osteoarthritis." Clin Ter. (Apr. 15, 1979) 89 (1) 75-86 (Eng. Abstr.).
Furber, M., et al. "New Synthetic Pathways from Gibberellins to Antheridiogens Isolated from the Fern Genus Anemia." Journal of Organic Chemistry, vol. 55, No. 15 (Jul. 1990) pp. 4860-4870.
Berkow, et al. "The Merck Manual." 16th Edition (1992) pp. 2401-2406.
Wu David Shine
Wu Minne
Australian Biomedical Company Pty. Ltd.
Shah Mukund J.
Truong Tamthom N.
LandOfFree
Gibberellins (including gibberellins A.sub.3 and A.sub.7) used i does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gibberellins (including gibberellins A.sub.3 and A.sub.7) used i, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gibberellins (including gibberellins A.sub.3 and A.sub.7) used i will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1073741